ArticleScientific data2025
A longitudinal MRI dataset of brain metastases with tumor segmentations, clinical & radiomic data.
Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain metastases (BM) are a severe complication of multiple primary malignancies and constitute the most frequent tumors of the central nervous system. Clinical imaging plays a crucial role in the management of BMs, serving as an essential tool for accurate diagnosis, effective treatment planning, and systematic follow-up care. However, progress in improving BM diagnosis and treatment is hindered by the limited availability of high-quality, annotated imaging datasets that reflect clinical variability in morphology, treatment planning, and patient characteristics. This study presents a comprehensive longitudinal dataset of 40 patients, including 744 MRI scans (baseline and follow-up), as well as 45 radiotherapy plans and 45 computed tomography scans. Detailed segmentations of 65 BMs are provided, defining three key tumor regions: enhancing tumor, edema, and necrotic core, offering a precise representation of tumor morphology for advanced quantitative analysis. This data-sharing initiative aims to support research efforts in automated BM detection, lesion segmentation, disease assessment, treatment planning, while contributing to the development of pertinent predictive and prognostic tools to enhance clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.